<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04361994</url>
  </required_header>
  <id_info>
    <org_study_id>00</org_study_id>
    <nct_id>NCT04361994</nct_id>
  </id_info>
  <brief_title>The GErman Italian Spanish Takotsubo (GEIST) Registry</brief_title>
  <acronym>GEIST</acronym>
  <official_title>The GErman Italian Spanish Takotsubo (GEIST) Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof. Dr. med. Ingo Eitel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Foggia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Luebeck</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      GEIST is a multicenter, international observational registry of patients with Takotsubo
      syndrome. Data regarding the clinical profile (demographic characteristics, clinical
      presentation, laboratory measures, electrocardiography /echocardiography / coronary
      angiography parameters, treatment and medication), in-hospital course and complications and
      short-/long-term outcome are collected prospectively and retrospectively to increase the
      understanding of the disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The open-ended, multicenter, international GEIST registry collects data from patients with
      Takotsubo syndrome during the index hospitalization and follow-up. Furthermore, long-term
      outcome data are acquired with structured telephone interviews, in case patients do not
      undergo regular outpatient visits in the participating study centers. The GEIST registry
      retrospectively includes data, which have already been collected, and prospectively continues
      to enroll patients with newly diagnosed Takotsubo syndrome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Anticipated">January 2025</completion_date>
  <primary_completion_date type="Anticipated">January 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>Day 0</time_frame>
    <description>All-cause mortality (in-hospital, short-term, long-term)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>3 Month</time_frame>
    <description>All-cause mortality (in-hospital, short-term, long-term)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>6 Month</time_frame>
    <description>All-cause mortality (in-hospital, short-term, long-term)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>In-Hospital complications</measure>
    <time_frame>Day 0</time_frame>
    <description>Cardiogenic shock, pulmonary edema, death, life-threatening arrhythmias, ventricular thrombus formation, right ventricular involvement</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Takotsubo Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Diagnosed according to the current diagnostic recommendations at the time of clinical
        presentation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Takotsubo syndrome

        Exclusion Criteria:

          -  Non
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ingo Eitel, Prof. Dr.</last_name>
    <phone>004945150044501</phone>
    <email>ingo.eitel@uksh.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Stiermaier, Dr.</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universität zu Lübeck</name>
      <address>
        <city>Lübeck</city>
        <state>Schleswig-Holstein</state>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingo Eitel, Prof. Dr. med.</last_name>
    </contact>
    <contact_backup>
      <last_name>Thomas Stiermaier, Dr.med</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Foggia</name>
      <address>
        <city>Foggia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franceso Santoro, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Daniele Brunetti, Prof. Dr.</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 22, 2020</study_first_submitted>
  <study_first_submitted_qc>April 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>May 8, 2020</last_update_submitted>
  <last_update_submitted_qc>May 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Luebeck</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Ingo Eitel</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Takotsubo Cardiomyopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

